With 332% growth year-on-year and $52 million in sales, cannabidiol (CBD) has taken the top spot as the best-selling herbal supplement in the natural channel, according to the 2018 HerbalGram Herb Market Report by the American Botanical Council.
Senate Majority Leader Mitch McConnell has introduced language into a congressional spending report that would require the FDA to issue formal enforcement discretion on the sale of hemp-derived CBD products within 120 days, clearing a path for the lawful...
Hemp/CBD player Aurora Cannabis announced a huge gain in sales in a fiscal year that saw the company sign a ‘research partnership’ with the UFC, a combat sports league.
Colorado-based Geocann has launched two CBG (cannabigerol) formulations, optimizing absorption and bioavailability by utilizing the VESIsorb drug delivery system.
Medical Marijuana Inc, despite its name one of the early players in the hemp/CBD supplement field, has announced sales increases topping 30% and a move to develop products based on additional cannabinoids.
The high variability of hemp plants now being grown in North America means claims of standardization should be take with a grain of salt, a botanical expert says.
Interest in CBD is “off the charts,” but those mulling the regulatory path forward for the hottest functional ingredient of the moment might be well advised to consider how other cannabinoids will fit into the regulatory framework going forward, says...
In a development reflective of the rapidly developing hemp and cannabis markets, research firm BDS Analytics has announced $7 million in new financing.
Colorado Gov. Jared Polis said the state intends to maintain its lead in the hemp industry by putting the full weight of state government behind its farmers and extractors. The state has taken a lead in shipping hemp plants and seeds to some Latin American...
FDA needs to act quickly on CBD regulations before a rapidly developing patchwork quilt of new rules promulgated in lower jurisdictions unduly complicates the situation.
